Long-term mortality in patients with type 2 diabetes undergoing coronary angiography: the impact of glucose-lowering treatment

被引：0
|
作者：
N. Saleh
P. Petursson
B. Lagerqvist
H. Skúladóttir
A. Svensson
B. Eliasson
S. Gudbjörnsdottir
K. Eeg-Olofsson
A. Norhammar
机构：
[1] Karolinska University Hospital,Cardiology Unit, Department of Medicine
[2] Sahlgrenska University Hospital,Department of Cardiology
[3] Uppsala University,Department of Medical Sciences
[4] Centre of Registers in Region Västra Götaland,Department of Medicine, Sahlgrenska University Hospital
[5] University of Gothenburg,undefined
来源：
Diabetologia | 2012年 / 55卷
关键词：
Coronary angiography; Coronary artery disease; Diabetes; Insulin; Mortality; Treatment;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2109 / 2117
页数：8
相关论文
共 50 条
  • [21] Avoiding hypoglycemia: a key to success for glucose-lowering therapy in type 2 diabetes
    Ahren, Bo
    VASCULAR HEALTH AND RISK MANAGEMENT, 2013, 9 : 155 - 163
  • [22] Lymphopenia and mortality among patients undergoing coronary angiography: Long-term follow-up study
    Zafrir, Barak
    Hussein, Sliman
    Jaffe, Ronen
    Barnett-Griness, Ofra
    Saliba, Walid
    CARDIOLOGY JOURNAL, 2022, 29 (04) : 637 - 646
  • [23] Prevalence, Clinical Correlates, and Use of Glucose-Lowering Drugs among Older Patients with Type 2 Diabetes Living in Long-Term Care Facilities
    Bo, Mario
    Gallo, Stefano
    Zanocchi, Mauro
    Maina, Paola
    Balcet, Luisa
    Bonetto, Martina
    Marchese, Lorenzo
    Mastrapasqua, Annalisa
    Ricauda, Nicoletta Aimonino
    JOURNAL OF DIABETES RESEARCH, 2015, 2015
  • [24] Mortality after cancer among patients with diabetes mellitus: effect of diabetes duration and treatment: (questionable) classification of diabetic patients based on combination of specific glucose-lowering drugs
    Sarah E. Holden
    Christian A. Bannister
    Craig J. Currie
    Diabetologia, 2014, 57 : 2001 - 2002
  • [25] Diabetes and mortality risk in patients undergoing coronary angiography: The KARDIO study
    Laukkanen, Jari A.
    Kunutsor, Setor K.
    Immonen, Jaakko
    Hernesniemi, Jussi
    Karvanen, Juha
    Eskola, Markku
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2024, 104 (04) : 743 - 750
  • [26] Mortality after cancer among patients with diabetes mellitus: effect of diabetes duration and treatment: (questionable) classification of diabetic patients based on combination of specific glucose-lowering drugs
    Holden, Sarah E.
    Bannister, Christian A.
    Currie, Craig J.
    DIABETOLOGIA, 2014, 57 (09) : 2001 - 2002
  • [27] Glucose-lowering therapy and cardiovascular outcomes in patients with type 2 diabetes mellitus and acute coronary syndrome
    Avogaro, Angelo
    Bonora, Enzo
    Consoli, Agostino
    Del Prato, Stefano
    Genovese, Stefano
    Giorgino, Francesco
    DIABETES & VASCULAR DISEASE RESEARCH, 2019, 16 (05) : 399 - 414
  • [28] Glucose-lowering therapies in type 2 diabetes: Opportunities and challenges for peptides
    Bailey, Clifford J.
    PEPTIDES, 2018, 100 : 9 - 17
  • [29] Long-term impact of bariatric surgery on glycemic control and glucose-lowering therapy for people with type 2 diabetes: population-based cohort study
    Imtiaz, Rameez
    Doumouras, Aristithes G.
    Hong, Dennis
    Anvari, Mehran
    Shah, Baiju R.
    SURGERY FOR OBESITY AND RELATED DISEASES, 2021, 17 (06) : 1049 - 1056
  • [30] Glucose-Lowering Drugs to Reduce Cardiovascular Risk in Type 2 Diabetes
    Kalyani, Rita R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (13) : 1248 - 1260
12345